This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Relating to long-term care services and Medical Assistance fair hearing process.
Submitted by the Department of Health Services.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to licensure requirements.
Submitted by the Occupational Therapists Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023.
Relating to continuing education.
Submitted by the Occupational Therapists Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023.
Relating to scheduling Serdexmethylphenidate.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling ten (10) fentanyl related substances.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Alfaxalone.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to Excluding 6-beta-Naltrexol.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Fospropofol.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Embutramide.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Perampanel.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Lacosamide.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to transferring 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to general updates.
Submitted by the Department of Veterans Affairs.
Report received from Agency, January 3, 2023.
Referred to the committee on Labor, Regulatory Reform, Veterans and Military Affairs, January 13, 2023.
Relating to the employment and entrepreneurship grants transition program.
Submitted by the Department of Veterans Affairs.
Report received from Agency, January 3, 2023.
Referred to the committee on Labor, Regulatory Reform, Veterans and Military Affairs, January 13, 2023.
Relating to telehealth.
Submitted by the Department of Health Services.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to the Clean Water Fund Program.
Submitted by the Department of Natural Resources.
Report received from Agency, January 3, 2023.
Referred to the committee on Natural Resources and Energy, January 13, 2023.
Relating to SeniorCare Prescription Drugs.
Submitted by the Department of Health Services.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to reciprocal credentials for service members, former service members, and their spouses.
Submitted by the Department of Safety and Professional Services.
Report received from Agency, January 3, 2023.
Loading...
Loading...